Selank

Also known as: TP-7

Cognitive Enhancement

Preclinical

Selank is a synthetic analog of the immunomodulatory peptide tuftsin that demonstrates both anxiolytic and nootropic properties. It is approved in Russia as an anxiolytic medication. Uniquely, it combines cognitive enhancement with immune modulation without the sedation or dependence associated with benzodiazepines.

Regulatory & Approval Status

Approved Internationally — Not US FDA

Selank is approved for use in Russia but remains an unapproved research compound in the United States.

Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.

Unlock the complete research profile

Create your free CertifiedTide account to access full compound details, mechanisms, safety data, and research tools.